Nandrolone phenylpropionate is known as an anabolic steroid that is valued for its ability to enhance strength and encourage the development of lean muscle mass Introduced in 1957 as Durabolin by Organon (now Merck/MSD), it has adapted its therapeutic roles over the years. Initially utilized for postoperative recovery and osteoporosis, its primary use today is in treating advanced metastatic breast cancer and osteoporosis in older patients. Athletes and bodybuilders favor it for enhancing performance without substantial androgenic or estrogenic side effects.Furthermore it proves advantageous, in treating a range of ailments such, as injuries and particular types of anemia highlighting its versatility as a treatment option.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.

FAQ

What is Nandrolone phenylpropionate?

Version of the anabolic steroid nandrolone that can be injected into the body and is comparable, to nandrolone decanoate.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

How does Nandrolone phenylpropionate differ from nandrolone decanoate?

The primary difference is the duration of action; phenylpropionate is active for about a week, while decanoate lasts approximately three weeks.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

When was Nandrolone phenylpropionate first described?

It was first described in 1957.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.